Ashapura Minechem Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 9:15 pm

Quick Insight

Ashapura Minechem Ltd, with a market capitalization of ₹4,799 Cr. and a share price of 502, boasts a healthy P/E ratio of 14.3, indicating a fair valuation. The company's robust ROE of 26.6% and ROCE of 17.1% reflect strong operational efficiency and effective capital utilization. However, its high P/BV ratio of 3.69x suggests the stock may be slightly overvalued based on its book value. With significant reserves of ₹1,223 Cr. and manageable borrowings of ₹1,163 Cr., Ashapura Minechem seems well-positioned to finance its operations. Investors should closely monitor the company's ability to maintain its profitability amidst any industry challenges to ensure sustained growth and shareholder value.

Competitors of Ashapura Minechem Ltd

All Competitor Stocks of Ashapura Minechem Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:30 pm

Below is a detailed analysis of the quarterly data for Ashapura Minechem Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,356.00 Cr.. The value appears strong and on an upward trend. It has increased from 555.00 Cr. (Mar 2025) to 1,356.00 Cr., marking an increase of 801.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,174.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 471.00 Cr. (Mar 2025) to 1,174.00 Cr., marking an increase of 703.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 182.00 Cr.. The value appears strong and on an upward trend. It has increased from 84.00 Cr. (Mar 2025) to 182.00 Cr., marking an increase of 98.00 Cr..
• For OPM %, as of Jun 2025, the value is 13.00%. The value appears to be declining and may need further review. It has decreased from 15.00% (Mar 2025) to 13.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 56.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 50.00 Cr..
• For Interest, as of Jun 2025, the value is 31.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.00 Cr. (Mar 2025) to 31.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 32.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 125.00 Cr.. The value appears strong and on an upward trend. It has increased from 82.00 Cr. (Mar 2025) to 125.00 Cr., marking an increase of 43.00 Cr..
• For Tax %, as of Jun 2025, the value is 14.00%. The value appears to be increasing, which may not be favorable. It has increased from 7.00% (Mar 2025) to 14.00%, marking an increase of 7.00%.
• For Net Profit, as of Jun 2025, the value is 114.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Mar 2025) to 114.00 Cr., marking an increase of 35.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 11.50. The value appears strong and on an upward trend. It has increased from 9.05 (Mar 2025) to 11.50, marking an increase of 2.45.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 5:24 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:28 pm

Below is a detailed analysis of the balance sheet data for Ashapura Minechem Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.00 Cr. (Mar 2024) to 19.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,223.00 Cr.. The value appears strong and on an upward trend. It has increased from 912.00 Cr. (Mar 2024) to 1,223.00 Cr., marking an increase of 311.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,163.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 984.00 Cr. (Mar 2024) to 1,163.00 Cr., marking an increase of 179.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,526.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,397.00 Cr. (Mar 2024) to 1,526.00 Cr., marking an increase of 129.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,931.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,311.00 Cr. (Mar 2024) to 3,931.00 Cr., marking an increase of 620.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,349.00 Cr.. The value appears strong and on an upward trend. It has increased from 577.00 Cr. (Mar 2024) to 1,349.00 Cr., marking an increase of 772.00 Cr..
• For CWIP, as of Mar 2025, the value is 55.00 Cr.. The value appears to be declining and may need further review. It has decreased from 504.00 Cr. (Mar 2024) to 55.00 Cr., marking a decrease of 449.00 Cr..
• For Investments, as of Mar 2025, the value is 344.00 Cr.. The value appears strong and on an upward trend. It has increased from 321.00 Cr. (Mar 2024) to 344.00 Cr., marking an increase of 23.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,181.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,909.00 Cr. (Mar 2024) to 2,181.00 Cr., marking an increase of 272.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,931.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,311.00 Cr. (Mar 2024) to 3,931.00 Cr., marking an increase of 620.00 Cr..

Notably, the Reserves (1,223.00 Cr.) exceed the Borrowings (1,163.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Ashapura Minechem Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 31.37. This value is within the healthy range. It has increased from 12.79 (Mar 23) to 31.37, marking an increase of 18.58.
• For Diluted EPS (Rs.), as of Mar 24, the value is 30.50. This value is within the healthy range. It has increased from 12.79 (Mar 23) to 30.50, marking an increase of 17.71.
• For Cash EPS (Rs.), as of Mar 24, the value is 33.85. This value is within the healthy range. It has increased from 18.00 (Mar 23) to 33.85, marking an increase of 15.85.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 100.26. It has increased from 71.84 (Mar 23) to 100.26, marking an increase of 28.42.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 100.26. It has increased from 71.84 (Mar 23) to 100.26, marking an increase of 28.42.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 290.08. It has increased from 200.12 (Mar 23) to 290.08, marking an increase of 89.96.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 33.66. This value is within the healthy range. It has increased from 28.28 (Mar 23) to 33.66, marking an increase of 5.38.
• For PBIT / Share (Rs.), as of Mar 24, the value is 25.07. This value is within the healthy range. It has increased from 20.34 (Mar 23) to 25.07, marking an increase of 4.73.
• For PBT / Share (Rs.), as of Mar 24, the value is 28.21. This value is within the healthy range. It has increased from 13.31 (Mar 23) to 28.21, marking an increase of 14.90.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 25.26. This value is within the healthy range. It has increased from 10.06 (Mar 23) to 25.26, marking an increase of 15.20.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 31.37. This value is within the healthy range. It has increased from 12.79 (Mar 23) to 31.37, marking an increase of 18.58.
• For PBDIT Margin (%), as of Mar 24, the value is 11.60. This value is within the healthy range. It has decreased from 14.12 (Mar 23) to 11.60, marking a decrease of 2.52.
• For PBIT Margin (%), as of Mar 24, the value is 8.64. This value is below the healthy minimum of 10. It has decreased from 10.16 (Mar 23) to 8.64, marking a decrease of 1.52.
• For PBT Margin (%), as of Mar 24, the value is 9.72. This value is below the healthy minimum of 10. It has increased from 6.65 (Mar 23) to 9.72, marking an increase of 3.07.
• For Net Profit Margin (%), as of Mar 24, the value is 8.70. This value is within the healthy range. It has increased from 5.02 (Mar 23) to 8.70, marking an increase of 3.68.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 10.81. This value is within the healthy range. It has increased from 6.39 (Mar 23) to 10.81, marking an increase of 4.42.
• For Return on Networth / Equity (%), as of Mar 24, the value is 30.85. This value is within the healthy range. It has increased from 17.60 (Mar 23) to 30.85, marking an increase of 13.25.
• For Return on Capital Employeed (%), as of Mar 24, the value is 12.97. This value is within the healthy range. It has increased from 11.50 (Mar 23) to 12.97, marking an increase of 1.47.
• For Return On Assets (%), as of Mar 24, the value is 8.66. This value is within the healthy range. It has increased from 3.83 (Mar 23) to 8.66, marking an increase of 4.83.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.73. This value is within the healthy range. It has decreased from 0.97 (Mar 23) to 0.73, marking a decrease of 0.24.
• For Total Debt / Equity (X), as of Mar 24, the value is 1.06. This value exceeds the healthy maximum of 1. It has decreased from 1.14 (Mar 23) to 1.06, marking a decrease of 0.08.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.83. It has increased from 0.66 (Mar 23) to 0.83, marking an increase of 0.17.
• For Current Ratio (X), as of Mar 24, the value is 1.19. This value is below the healthy minimum of 1.5. It has decreased from 1.28 (Mar 23) to 1.19, marking a decrease of 0.09.
• For Quick Ratio (X), as of Mar 24, the value is 0.85. This value is below the healthy minimum of 1. It has decreased from 0.91 (Mar 23) to 0.85, marking a decrease of 0.06.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.71. This value is below the healthy minimum of 4. It has decreased from 0.94 (Mar 23) to 0.71, marking a decrease of 0.23.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 4.42. This value is within the healthy range. It has increased from 4.02 (Mar 23) to 4.42, marking an increase of 0.40.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.90. This value is below the healthy minimum of 3. It has increased from 2.43 (Mar 23) to 2.90, marking an increase of 0.47.
• For Enterprise Value (Cr.), as of Mar 24, the value is 4,259.26. It has increased from 1,694.73 (Mar 23) to 4,259.26, marking an increase of 2,564.53.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.60. This value is within the healthy range. It has increased from 0.92 (Mar 23) to 1.60, marking an increase of 0.68.
• For EV / EBITDA (X), as of Mar 24, the value is 13.83. This value is within the healthy range. It has increased from 6.55 (Mar 23) to 13.83, marking an increase of 7.28.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.29. This value is within the healthy range. It has increased from 0.55 (Mar 23) to 1.29, marking an increase of 0.74.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Price / BV (X), as of Mar 24, the value is 3.69. This value exceeds the healthy maximum of 3. It has increased from 1.54 (Mar 23) to 3.69, marking an increase of 2.15.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.29. This value is within the healthy range. It has increased from 0.55 (Mar 23) to 1.29, marking an increase of 0.74.
• For EarningsYield, as of Mar 24, the value is 0.08. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 23) to 0.08, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness